Orthofix Medical Inc. Payments of Debt Issuance Costs
Orthofix Medical Inc. (OFIX) reported Payments of Debt Issuance Costs of $24.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-05
- Orthofix Medical Inc. payments of debt issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. payments of debt issuance costs for the quarter ending 2026-03-31 was $24.00K, a 95.31% decline year-over-year.
- Orthofix Medical Inc. payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. payments of debt issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. payments of debt issuance costs for fiscal 2025 was $531.00K, a 85.37% decline from fiscal 2024.
- Orthofix Medical Inc. payments of debt issuance costs for fiscal 2024 was $3.63M, a 54.01% increase from fiscal 2023.
- Orthofix Medical Inc. payments of debt issuance costs for fiscal 2023 was $2.36M, a 2461.96% increase from fiscal 2022.
- Orthofix Medical Inc. payments of debt issuance costs for fiscal 2022 was $92.00K, a 90.30% decline from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $24.00K 10-Q · filed 2026-08-05 | $24.00K derived: sum of 3 quarters · filed 2026-08-05 | $24.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-05 | $24.00K derived: sum of 2 quarters · filed 2026-05-05 | $24.00K derived: sum of 3 quarters · filed 2026-05-05 | $43.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $19.00K derived: sum of 3 quarters · filed 2026-08-05 | $531.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $19.00K derived: sum of 2 quarters · filed 2026-08-05 | $531.00K 10-Q · filed 2025-11-04 | $1.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $531.00K 10-Q · filed 2026-08-05 | $1.54M derived: sum of 3 quarters · filed 2026-08-05 | $1.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $512.00K 10-Q · filed 2026-05-05 | $1.52M derived: sum of 2 quarters · filed 2026-05-05 | $1.75M derived: sum of 3 quarters · filed 2026-05-05 | $2.60M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.24M derived: sum of 2 quarters · filed 2026-02-24 | $2.08M derived: sum of 3 quarters · filed 2026-02-24 | $3.63M 10-K · filed 2026-02-24 |
| 2024-09-30 | $225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.07M derived: sum of 2 quarters · filed 2025-11-04 | $2.62M 10-Q · filed 2025-11-04 | $4.28M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $845.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.39M 10-Q · filed 2025-08-05 | $4.05M derived: sum of 3 quarters · filed 2026-02-24 | $4.47M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.55M 10-Q · filed 2025-05-06 | $3.21M derived: sum of 2 quarters · filed 2026-02-24 | $3.62M derived: sum of 3 quarters · filed 2026-02-24 | |
| 2023-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.08M derived: sum of 2 quarters · filed 2026-02-24 | $2.36M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $699.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $280.00K 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $92.00K 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $948.00K 10-K · filed 2024-03-05 | |||
| 2020-12-31 | $1.54M 10-K · filed 2023-03-06 | |||
| 2019-12-31 | $3.02M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $682.00K 10-K · filed 2021-02-26 | |||
| 2018-03-31 | $165.00K 10-Q · filed 2018-04-30 | |||
| 2017-12-31 | $445.00K 10-K · filed 2020-02-24 | |||
| 2015-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.82M 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $1.72M 10-Q · filed 2016-10-31 | |||
| 2012-09-30 | $5.00M 10-Q · filed 2012-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |